NorthWest Biotherapeutics Inc (NWBO)

[XMaster2023]

LC I thought you admired NO Cure’s CEO Asaf Danziger. I guess now you will follow Ashley Cordova.
When you say ”Investors prefer leaders who are committed long-term and stand to benefit personally from an increase in the company’s value.” Are you talking about being a short? Perhaps you should invest in NVCR?

Truth is, LP is committed to NWBO and has not sold one share since I have invested. However, even though she will gain financially from her investment, I don’t believe it is her primary goal. I believe she wants to see a cure for Cancer. Since I invested in NWBO, there have been several tactical changes such as the purchase of Flaskworks and partnership with Roswell both were unexpected and stand to add significant value to NWBO. LP has also pursued legal action against the 7 market makers who threaten the existence of NWBO.
Most longs believe approval is near and all evidence is that LP has made another deal. Who that deal is with is unknown. I believe it must be contingent upon approval. This would be excellent news.
So getting back to your statement above, LP and all investors will benefit from the material event that is before us. LP is an excellent CEO.